The digital fix for addiction

You’ve heard about the opioid epidemic by now; last week an Ohio police department posted a controversial and haunting image to show “what [they] are now dealing with on a daily basis"—3K died from overdoses last year in Ohio alone. We’re enormously proud of portfolio company Chrono Therapeutics’ novel approach to combatting addiction (starting with nicotine)—and thrilled to announce they've raised an additional $47.6M in funding.

PS: Here's a cool new tool from Pew to map prescription drug use.



Company Amt Investors Source
Chrono Therapeutics $47.6M Kaiser Permanente Ventures, Cota Capital, Emergent Medical Partners, Mission Bay Capital, Canaan Partners, 5AM Ventures, Fountain Health Partners, GE Ventures, Mayo Clinic Forbes
PillPack $31.1M Astral Capital, Accomplice, Accel Partners, Charles River Ventures, Sherpa Capital Fortune

Get the full roundup of digital health funding deals since 2011. Subscribe to our funding database.